Acute Healthcare (Research)Research

Healthcare Client Story 2
The Process: Oncology
Client Sector: Acute Healthcare
Services: Research


Compare and contrast Intravenous and Subcutaneous (SC) treatment in patients with HER2-positive breast cancer.


On average, the total healthcare provider (HCP) time saved per SC treatment cycle relative to IV treatment cycle was 59.21 minutes. Time savings in favour of SC resulted from quicker drug reconstitution, no IV catheter installation and removal, and less HCP monitoring. Over a full treatment course of 17 cycles, average HCP time saved accumulates to 16.78 hours. Loss of productivity for patients receiving IV (2.15 days) was greater than that of SC (0.60 days) for a full treatment course.

I highly recommend the ability and professionalism of ReganStein, whose leadership experience in ICT, hands on approach and willingness to immerse themselves into our business for a period of several weeks has provided us with a confidence to address the future.

Ruth Buckley
Head of ICT, Cork City Council

Looking for a First-Class Business Specialist?